While stomach cancer rates in the United States have declined overall in recent decades, a concerning trend has emerged among younger populations. People under 50, particularly women, are experiencing increased rates of early-onset stomach cancer, often diagnosed at more advanced stages. Although the reasons behind this shift remain unclear, early detection significantly improves survival outcomes. Dr. Mojun Zhu, a Mayo Clinic medical oncologist specializing in gastrointestinal cancers, emphasizes that understanding family history and recognizing symptoms can lead to earlier diagnosis before the cancer spreads.
Recognizing Subtle Symptoms
Early stomach cancer often presents with vague symptoms that people may dismiss or self-treat with over-the-counter medications. “The symptoms are nonspecific and overlap with many benign conditions,” explains Dr. Zhu. Many young patients attribute their discomfort to indigestion or acid reflux, delaying medical consultation until the cancer has progressed. Advanced stomach cancer may cause more noticeable symptoms like fatigue, unexplained weight loss, loss of appetite, feeling full after small meals, anemia, vomiting blood, or black stools—symptoms that typically prompt people to seek medical attention.
The Critical Role of Family History
For individuals at average risk, there are no standard screening recommendations for stomach cancer. However, those with symptoms and a family history of cancer may benefit from additional evaluation. Dr. Zhu stresses the importance of knowing both first-degree (parents, siblings, children) and second-degree (grandparents, aunts, uncles) family history. “If relatives were diagnosed with breast, stomach, or other gastrointestinal cancers before age 50, discuss genetic testing or counseling with your healthcare provider,” she advises. Genetic conditions increasing stomach cancer risk include Lynch syndrome, juvenile polyposis syndrome, Peutz-Jeghers syndrome, familial adenomatous polyposis, and hereditary diffuse gastric cancer caused by CDH1 gene mutations.
Advances in Treatment Approaches
Although stomach cancer can be aggressive with higher mortality rates than some other cancers, treatment options are evolving. Early-stage, localized stomach cancer may be curable with surgery alone. However, stages 2 and 3 carry recurrence risks up to 50% despite surgery and chemotherapy. Researchers are investigating new screening methods, including MRI trials for high-risk individuals, and advancing minimally invasive techniques like endoscopic resection to preserve stomach function. For advanced cases, new therapies showing promise include immunotherapy, targeted drugs, antibody-drug conjugates, bispecific antibodies, and hyperthermic intraperitoneal chemotherapy (HIPEC), recently approved combinations for certain HER2-negative advanced cancers.
Taking Proactive Steps
With stomach cancer patients facing up to a 50% risk of developing peritoneal cancer even after stomach removal, researchers are developing new intraperitoneal treatments to reduce this risk. Despite unanswered questions about rising rates in young adults, being aware of family history and symptoms remains crucial. Dr. Zhu’s final recommendation is clear: “Don’t delay—if you experience new symptoms consistent with stomach cancer, consult your healthcare professional to discuss whether screening or genetic testing is appropriate for you.”
Related topics
